Literature DB >> 20388540

Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells.

Manuela Mancini1, Sara Petta, Ilaria Iacobucci, Valentina Salvestrini, Enza Barbieri, Maria Alessandra Santucci.   

Abstract

Slug, a Snail-related zinc-finger transcription factor implicated in the increased motility of mesenchymal cells during embryonic development and progression of cancer cells towards an invasive phenotype, plays a specific and critical role in the pathogenesis of Bcr-Abl-associated leukemias. Here we report that Slug over-expression associated with Bcr-Abl is conditional upon the tyrosine kinase (TK) activity of 210 fusion protein. Slug over-expression is driven by transcriptional events eventually integrated by post-transcriptional mechanisms leading to protein stabilization and is at least partly regulated by the ERK1/2 mitogen-activated protein kinase (MAPK). It contributes to apoptosis resistance of leukemic progenitors through the repression of pro-apoptotic Puma. Moreover, Slug is a component of leukemic progenitor resistance to imatinib mesylate (IM) driven by Bcr-Abl point mutations and, in particular, by T315I. Slug over-expression associated with p210 Bcr-Abl TK either in the wild type (wt) or mutated conformation results in a significant reduction of E-cadherin, the substrate of Beta catenin at cell membranes. In conclusion, our results suggest that Slug has a central role in a complex network involved in prolonged survival and IM resistance of CML progenitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388540     DOI: 10.1016/j.cellsig.2010.04.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  16 in total

1.  SLUG is a direct transcriptional repressor of PTEN tumor suppressor.

Authors:  Berna Uygur; Katrina Abramo; Evgenia Leikina; Calvin Vary; Lucy Liaw; Wen-Shu Wu
Journal:  Prostate       Date:  2015-03-01       Impact factor: 4.104

2.  Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cells.

Authors:  Koichiro Tsukasa; Qiang Ding; Makoto Yoshimitsu; Yumi Miyazaki; Shyuichiro Matsubara; Sonshin Takao
Journal:  Hum Cell       Date:  2015-05-22       Impact factor: 4.174

Review 3.  Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?

Authors:  Jente van Staalduinen; David Baker; Peter Ten Dijke; Hans van Dam
Journal:  Oncogene       Date:  2018-07-12       Impact factor: 9.867

Review 4.  The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome.

Authors:  Andrew D Redfern; Lisa J Spalding; Erik W Thompson
Journal:  Clin Exp Metastasis       Date:  2018-06-08       Impact factor: 5.150

5.  Targeting of slug sensitizes anaplastic thyroid carcinoma SW1736 cells to doxorubicin via PUMA upregulation.

Authors:  Anbing Dong; Xuelong Jiao; Dong Chen; Fengyun Hao; Kejun Zhang
Journal:  Int J Biochem Mol Biol       Date:  2016-09-30

Review 6.  Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links.

Authors:  Christina Scheel; Robert A Weinberg
Journal:  Semin Cancer Biol       Date:  2012-04-23       Impact factor: 15.707

Review 7.  Twist as a new prognostic marker in hematological malignancies.

Authors:  F Norozi; A Ahmadzadeh; M Shahjahani; S Shahrabi; N Saki
Journal:  Clin Transl Oncol       Date:  2015-07-24       Impact factor: 3.405

8.  Targeting SLUG sensitizes leukemia cells to ADR-induced apoptosis.

Authors:  Chang-Rong Wei; Jun Liu; Xiao-Jun Yu
Journal:  Int J Clin Exp Med       Date:  2015-12-15

9.  RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA.

Authors:  Kejun Zhang; Dong Chen; Xingang Wang; Shaoyan Zhang; Jigang Wang; Yuan Gao; Bomin Yan
Journal:  Int J Mol Sci       Date:  2011-01-14       Impact factor: 5.923

10.  Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells.

Authors:  Elisabetta Lambertini; Andrea Lolli; Federica Vezzali; Letizia Penolazzi; Roberto Gambari; Roberta Piva
Journal:  BMC Cancer       Date:  2012-10-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.